查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1942818

2026年全球血管內血管支架市場報告

Endovascular Stent Grafts Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，血管內血管支架市場呈指數級成長，預計將從2025年的14.5億美元成長到2026年的19.9億美元，複合年成長率達37.9%。成長要素包括對傳統開放性手術的依賴、先進血管支架物材料的供不應求、血管疾病患病率的上升、冠狀動脈和周邊血管移植物早期應用以及人們對主動脈瘤治療認知的提高。

預計未來幾年，血管內血管支架市場將快速成長，到2030年市場規模將達到71.3億美元，複合年成長率（CAGR）為37.5%。預測期內的成長要素包括血管內血管支架物技術的創新、微創手術的興起、主動脈瘤和主動脈夾層病例的增加、混合血管移植物應用的日益普及以及心血管基礎設施的不斷完善。預測期內的主要趨勢包括微創血管內治療方法的日益普及、對客製化血管支架需求的成長、混合和生物材料移植物技術的進步、胸主動脈和腹主動脈修復手術的擴展以及對患者安全和監管合規性的日益重視。

心血管疾病盛行率的不斷上升正在推動血管內血管支架市場的未來擴張。心血管疾病是指影響心臟和血管的一系列疾病。心血管疾病盛行率的上升受生活型態、先前基礎疾病、遺傳易感性和環境因素的影響。血管內血管支架可以加強脆弱的血管壁，降低破裂風險，並提供有效的治療方案，在最大限度減少侵入性手術干預的同時改善患者預後。例如，根據澳洲政府機構—澳洲健康與福利研究所 (AIHW) 的數據，截至 2025 年 10 月，預計到 2023 年，約有 57,100 名 25 歲及以上的成年人將患上急性冠狀動脈症候群，平均每天約有 156 例。因此，心血管疾病盛行率的不斷上升正在增強血管內血管支架市場的需求。

血管內血管支架市場的主要企業正致力於開發創新產品，例如胸主動脈血管支架，以提高治療精準度、改善患者預後並應對複雜的解剖結構挑戰。胸主動脈血管支架是一種專門用於透過血管內手術治療胸主動脈疾病的醫療設備，提供了一種安全有效的微創治療方案。例如，2024年2月，中國醫療設備製造商恩多斯泰克（Endovastec）推出了多分支胸主動脈血管支架系統（Hector），並在瑞士完成了首次臨床應用。此系統的多分支設計能夠在治療複雜胸主動脈疾病的同時，維持關鍵動脈分支的血流。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球血管內血管支架市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 工業4.0和智慧製造
    • 生物技術、基因組學和精準醫學
    • 數位化、雲端運算、巨量資料、網路安全
    • 自主系統、機器人與智慧運輸
    • 物聯網、智慧基礎設施和互聯生態系統
  • 主要趨勢
    • 微創血管內治療方法的普及應用日益廣泛
    • 對客製化血管支架的需求不斷成長
    • 混合和生物接枝材料的進展
    • 擴大胸腹主動脈修補手術
    • 更加重視病人安全和監管合規性

第5章 終端用戶產業市場分析

  • 循環系統專科醫院
  • 綜合醫院
  • 專科手術中心
  • 醫療設備製造商
  • 研究和學術機構

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球血管內血管支架市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 全球血管內血管支架市場規模、比較及成長率分析
  • 全球血管內血管支架市場表現：規模與成長，2020-2025年
  • 全球血管內血管支架市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 依產品
  • 血液透析通路移植、血管內血管支架、冠狀動脈繞道手術移植、主動脈疾病血管移植、周邊血管移植
  • 按原料
  • 合成血管移植物、生物血管移植物、混合血管移植物
  • 透過使用
  • 心臟動脈瘤、腎衰竭、血管阻塞、冠狀動脈疾病
  • 按類型細分：血液透析通路移植
  • 動靜脈瘻管移植片、合成血液透析通路移植片、生物工程血液透析通路移植片、塗層血液透析移植片、血管內血液透析移植片
  • 按類型細分：血管內血管支架
  • 用於動脈瘤的血管支架、主動脈夾層的血管支架、胸腔血管內血管支架、腹腔血管內支架血管支架、膽道血管內血管支架
  • 按類型細分：冠狀動脈繞道手術手術
  • 大隱靜脈移植（SVG）、動脈冠狀動脈繞道手術手術、血管內冠狀動脈繞道手術手術（CABG）、人工冠狀動脈繞道手術手術
  • 按類型細分：主動脈疾病血管移植
  • 血管內主動脈血管支架、主動脈瘤移植物、主動脈繞道移植、胸腹主動脈血管支架、主動脈血管支架
  • 按類型細分：周邊血管移植
  • 頸動脈血管支架、股動脈血管支架、膕動脈血管支架、髂動脈血管支架、周邊血管內血管支架

第10章 區域與國家分析

  • 全球血管內血管支架市場：依地區、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測
  • 全球血管內血管支架市場：國家、市場表現及預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 血管內血管支架市場：競爭格局與市場佔有率，2024 年
  • 血管內血管支架市場：公司估值矩陣
  • 血管內血管支架市場：公司概況
    • Abbott Laboratories
    • Medtronic PLC
    • Boston Scientific Corporation
    • Terumo Corporation
    • Cook Group Incorporated

第37章：其他領先和創新企業

  • Merit Medical Systems Inc., Biotronik SE & Co KG, MicroPort Scientific Corporation, Endologix LLC, LeMaitre Vascular Inc., Lifetech Scientific Corporation, WL Gore & Associates Inc., Braile Biomedica, BrosMed Medical BV, Micro Interventional Devices Inc.（MID）, Lombard Medical Inc., Endovastec Medical Technology Co Ltd., Jotec GmbH, Bentley InnoMed GmbH, Bolton Medical Inc.

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年血管內血管支架市場：提供新機會的國家
  • 2030年血管內血管支架市場：充滿新機會的細分市場
  • 2030年血管內血管支架市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME5MESGT01_G26Q1

Endovascular stent grafts are medical devices used to treat blood vessel problems such as aneurysms or narrowing. They consist of a metal mesh tube covered with a fabric graft and are inserted into the affected vessel through a catheter, usually via a large artery in the groin or arm. These devices repair damaged or weakened vessels and offer a less invasive alternative to open surgery.

The main product categories of endovascular stent grafts include hemodialysis access grafts, endovascular stent grafts, coronary artery bypass grafts, vascular grafts for aortic disease, and peripheral vascular grafts. Hemodialysis access grafts are specialized vascular grafts designed to create access for hemodialysis in patients with renal failure. The raw materials include synthetic vascular grafts, biological vascular grafts, and hybrid vascular grafts, which are used in applications such as cardiac aneurysms, kidney failure, vascular occlusions, and coronary artery diseases.

Tariffs are impacting the endovascular stent graft market by increasing costs of imported stent materials, including metal alloys and biologic graft fabrics. Segments like thoracic and abdominal endovascular stent grafts are most impacted, particularly in Asia-Pacific regions such as China and India, which are major production and import hubs. The resulting higher costs and potential supply chain delays have prompted manufacturers to explore local sourcing and production. Positively, tariffs have encouraged investment in domestic manufacturing capabilities and innovation in cost-efficient stent graft solutions.

The endovascular stent grafts market research report is one of a series of new reports from The Business Research Company that provides endovascular stent grafts market statistics, including endovascular stent grafts industry global market size, regional shares, competitors with a endovascular stent grafts market share, detailed endovascular stent grafts market segments, market trends and opportunities, and any further data you may need to thrive in the endovascular stent grafts industry. This endovascular stent grafts market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The endovascular stent grafts market size has grown exponentially in recent years. It will grow from $1.45 billion in 2025 to $1.99 billion in 2026 at a compound annual growth rate (CAGR) of 37.9%. The growth in the historic period can be attributed to reliance on conventional open surgical procedures, limited availability of advanced stent graft materials, growing prevalence of vascular diseases, early adoption of coronary and peripheral grafts, increasing awareness of aortic aneurysm treatments.

The endovascular stent grafts market size is expected to see exponential growth in the next few years. It will grow to $7.13 billion in 2030 at a compound annual growth rate (CAGR) of 37.5%. The growth in the forecast period can be attributed to technological innovations in endovascular stent grafts, rising minimally invasive surgeries, growth in aortic aneurysm and dissection cases, increasing adoption of hybrid vascular grafts, expansion of cardiovascular healthcare infrastructure. Major trends in the forecast period include increasing adoption of minimally invasive endovascular procedures, rising demand for customized stent grafts, advancements in hybrid and biologic graft materials, expansion of thoracic and abdominal aortic repair procedures, enhanced focus on patient safety and regulatory compliance.

The increasing prevalence of cardiovascular diseases is increasingly supporting the expansion of the endovascular stent graft market going forward. Cardiovascular disease refers to a broad category of conditions involving the heart or blood vessels. The rising prevalence of cardiovascular diseases is influenced by lifestyle behaviors, pre-existing medical conditions, genetic predispositions, and environmental factors. Endovascular stent grafts provide an effective treatment option by reinforcing weakened blood vessel walls, reducing rupture risk, and minimizing invasive surgical intervention while improving patient outcomes. For example, in October 2025, according to the Australian Institute of Health and Welfare, an Australia-based government agency, an estimated 57,100 adults aged 25 years and older experienced acute coronary events in 2023, averaging approximately 156 cases per day. As a result, the growing prevalence of cardiovascular diseases is strengthening demand within the endovascular stent graft market.

Leading companies operating in the endovascular stent grafts market are focused on developing innovative products such as thoracic aortic stent grafts to improve treatment precision, enhance patient outcomes, and address complex anatomical challenges. A thoracic aortic stent graft is a specialized device used in endovascular surgery to manage diseases of the thoracic aorta by providing a safe and effective minimally invasive treatment option. For example, in February 2024, Endovastec, a China-based medical device company, introduced the Multi-Branch Thoracic Aortic Stent-Graft System (Hector) and completed its first clinical application in Switzerland. The system's multi-branch design allows treatment of complex thoracic aortic conditions while preserving blood flow to critical arterial branches.

In December 2023, TekniPlex Healthcare Inc., a US-based provider of medical device components, acquired Seisa Medical S.A. de C.V. for an undisclosed amount. Through this acquisition, TekniPlex aims to expand its medical device manufacturing capabilities and strengthen its presence in the Latin American healthcare market. Seisa Medical S.A. de C.V. is a Mexico-based manufacturer specializing in endovascular stent grafts.

Major companies operating in the endovascular stent grafts market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Terumo Corporation, Cook Group Incorporated, Merit Medical Systems Inc., Biotronik SE & Co KG, MicroPort Scientific Corporation, Endologix LLC, LeMaitre Vascular Inc., Lifetech Scientific Corporation, W. L. Gore & Associates Inc., Braile Biomedica, BrosMed Medical BV, Micro Interventional Devices Inc. (MID), Lombard Medical Inc., Endovastec Medical Technology Co Ltd., Jotec GmbH, Bentley InnoMed GmbH, Bolton Medical Inc., Alvimedica, Endospan Ltd., Vivasure Medical Ltd.

North America was the largest region in the endovascular stent grafts market in 2025. The regions covered in the endovascular stent grafts market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the endovascular stent grafts market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The endovascular stent grafts market consists of sales of aortoiliac stent grafts, thoracic endograft, and abdominal endografts. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Endovascular Stent Grafts Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses endovascular stent grafts market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for endovascular stent grafts ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The endovascular stent grafts market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Hemodialysis Access Grafts; Endovascular Stent Grafts; Coronary Artery By-Pass Grafts; Vascular Grafts For Aorta Disease; Peripheral Vascular Grafts
  • 2) By Raw Material: Synthetic Vascular Grafts; Biological Vascular Grafts; Hybrid Vascular Grafts
  • 3) By Application: Cardiac Aneurysm; Kidney Failure; Vascular Occlusion; Coronary Artery Disease
  • Subsegments:
  • 1) By Hemodialysis Access Grafts: Arteriovenous (AV) Fistula Grafts; Synthetic Hemodialysis Access Grafts; Bioengineered Hemodialysis Access Grafts; Coated Hemodialysis Grafts; Endovascular Hemodialysis Grafts
  • 2) By Endovascular Stent Grafts: Aneurysm Stent Grafts; Stent Grafts For Aortic Dissection; Thoracic Endovascular Stent Grafts; Abdominal Endovascular Stent Grafts; Biliary Endovascular Stent Grafts
  • 3) By Coronary Artery By-Pass Grafts: Saphenous Vein Grafts (SVG); Arterial Coronary Bypass Grafts; Endovascular Coronary Artery Bypass Grafts (CABG); Synthetic Coronary Bypass Grafts
  • 4) By Vascular Grafts For Aorta Disease: Endovascular Aortic Stent Grafts; Aortic Aneurysm Grafts; Aortic Bypass Grafts; Thoracoabdominal Aortic Stent Grafts; Aortic Dissection Stent Grafts
  • 5) By Peripheral Vascular Grafts: Carotid Artery Stent Grafts; Femoral Artery Stent Grafts; Popliteal Artery Stent Grafts; Iliac Artery Stent Grafts; Peripheral Endovascular Stent Grafts
  • Companies Mentioned: Abbott Laboratories; Medtronic PLC; Boston Scientific Corporation; Terumo Corporation; Cook Group Incorporated; Merit Medical Systems Inc.; Biotronik SE & Co KG; MicroPort Scientific Corporation; Endologix LLC; LeMaitre Vascular Inc.; Lifetech Scientific Corporation; W. L. Gore & Associates Inc.; Braile Biomedica; BrosMed Medical BV; Micro Interventional Devices Inc. (MID); Lombard Medical Inc.; Endovastec Medical Technology Co Ltd.; Jotec GmbH; Bentley InnoMed GmbH; Bolton Medical Inc.; Alvimedica; Endospan Ltd.; Vivasure Medical Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Endovascular Stent Grafts Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Endovascular Stent Grafts Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Endovascular Stent Grafts Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Endovascular Stent Grafts Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Industry 4.0 & Intelligent Manufacturing
    • 4.1.2 Biotechnology, Genomics & Precision Medicine
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Autonomous Systems, Robotics & Smart Mobility
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Minimally Invasive Endovascular Procedures
    • 4.2.2 Rising Demand For Customized Stent Grafts
    • 4.2.3 Advancements In Hybrid And Biologic Graft Materials
    • 4.2.4 Expansion Of Thoracic And Abdominal Aortic Repair Procedures
    • 4.2.5 Enhanced Focus On Patient Safety And Regulatory Compliance

5. Endovascular Stent Grafts Market Analysis Of End Use Industries

  • 5.1 Cardiovascular Hospitals
  • 5.2 General Hospitals
  • 5.3 Specialized Surgical Centers
  • 5.4 Medical Device Manufacturers
  • 5.5 Research And Academic Institutions

6. Endovascular Stent Grafts Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Endovascular Stent Grafts Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Endovascular Stent Grafts PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Endovascular Stent Grafts Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Endovascular Stent Grafts Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Endovascular Stent Grafts Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Endovascular Stent Grafts Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Endovascular Stent Grafts Market Segmentation

  • 9.1. Global Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hemodialysis Access Grafts, Endovascular Stent Grafts, Coronary Artery By-Pass Grafts, Vascular Grafts For Aorta Disease, Peripheral Vascular Grafts
  • 9.2. Global Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Synthetic Vascular Grafts, Biological Vascular Grafts, Hybrid Vascular Grafts
  • 9.3. Global Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cardiac Aneurysm, Kidney Failure, Vascular Occlusion, Coronary Artery Disease
  • 9.4. Global Endovascular Stent Grafts Market, Sub-Segmentation Of Hemodialysis Access Grafts, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Arteriovenous (AV) Fistula Grafts, Synthetic Hemodialysis Access Grafts, Bioengineered Hemodialysis Access Grafts, Coated Hemodialysis Grafts, Endovascular Hemodialysis Grafts
  • 9.5. Global Endovascular Stent Grafts Market, Sub-Segmentation Of Endovascular Stent Grafts, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Aneurysm Stent Grafts, Stent Grafts For Aortic Dissection, Thoracic Endovascular Stent Grafts, Abdominal Endovascular Stent Grafts, Biliary Endovascular Stent Grafts
  • 9.6. Global Endovascular Stent Grafts Market, Sub-Segmentation Of Coronary Artery By-Pass Grafts, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Saphenous Vein Grafts (SVG), Arterial Coronary Bypass Grafts, Endovascular Coronary Artery Bypass Grafts (CABG), Synthetic Coronary Bypass Grafts
  • 9.7. Global Endovascular Stent Grafts Market, Sub-Segmentation Of Vascular Grafts For Aorta Disease, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Endovascular Aortic Stent Grafts, Aortic Aneurysm Grafts, Aortic Bypass Grafts, Thoracoabdominal Aortic Stent Grafts, Aortic Dissection Stent Grafts
  • 9.8. Global Endovascular Stent Grafts Market, Sub-Segmentation Of Peripheral Vascular Grafts, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Carotid Artery Stent Grafts, Femoral Artery Stent Grafts, Popliteal Artery Stent Grafts, Iliac Artery Stent Grafts, Peripheral Endovascular Stent Grafts

10. Endovascular Stent Grafts Market Regional And Country Analysis

  • 10.1. Global Endovascular Stent Grafts Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Endovascular Stent Grafts Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Endovascular Stent Grafts Market

  • 11.1. Asia-Pacific Endovascular Stent Grafts Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Endovascular Stent Grafts Market

  • 12.1. China Endovascular Stent Grafts Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Endovascular Stent Grafts Market

  • 13.1. India Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Endovascular Stent Grafts Market

  • 14.1. Japan Endovascular Stent Grafts Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Endovascular Stent Grafts Market

  • 15.1. Australia Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Endovascular Stent Grafts Market

  • 16.1. Indonesia Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Endovascular Stent Grafts Market

  • 17.1. South Korea Endovascular Stent Grafts Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Endovascular Stent Grafts Market

  • 18.1. Taiwan Endovascular Stent Grafts Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Endovascular Stent Grafts Market

  • 19.1. South East Asia Endovascular Stent Grafts Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Endovascular Stent Grafts Market

  • 20.1. Western Europe Endovascular Stent Grafts Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Endovascular Stent Grafts Market

  • 21.1. UK Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Endovascular Stent Grafts Market

  • 22.1. Germany Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Endovascular Stent Grafts Market

  • 23.1. France Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Endovascular Stent Grafts Market

  • 24.1. Italy Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Endovascular Stent Grafts Market

  • 25.1. Spain Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Endovascular Stent Grafts Market

  • 26.1. Eastern Europe Endovascular Stent Grafts Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Endovascular Stent Grafts Market

  • 27.1. Russia Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Endovascular Stent Grafts Market

  • 28.1. North America Endovascular Stent Grafts Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Endovascular Stent Grafts Market

  • 29.1. USA Endovascular Stent Grafts Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Endovascular Stent Grafts Market

  • 30.1. Canada Endovascular Stent Grafts Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Endovascular Stent Grafts Market

  • 31.1. South America Endovascular Stent Grafts Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Endovascular Stent Grafts Market

  • 32.1. Brazil Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Endovascular Stent Grafts Market

  • 33.1. Middle East Endovascular Stent Grafts Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Endovascular Stent Grafts Market

  • 34.1. Africa Endovascular Stent Grafts Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Endovascular Stent Grafts Market, Segmentation By Product, Segmentation By Raw Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Endovascular Stent Grafts Market Regulatory and Investment Landscape

36. Endovascular Stent Grafts Market Competitive Landscape And Company Profiles

  • 36.1. Endovascular Stent Grafts Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Endovascular Stent Grafts Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Endovascular Stent Grafts Market Company Profiles
    • 36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Cook Group Incorporated Overview, Products and Services, Strategy and Financial Analysis

37. Endovascular Stent Grafts Market Other Major And Innovative Companies

  • Merit Medical Systems Inc., Biotronik SE & Co KG, MicroPort Scientific Corporation, Endologix LLC, LeMaitre Vascular Inc., Lifetech Scientific Corporation, W. L. Gore & Associates Inc., Braile Biomedica, BrosMed Medical BV, Micro Interventional Devices Inc. (MID), Lombard Medical Inc., Endovastec Medical Technology Co Ltd., Jotec GmbH, Bentley InnoMed GmbH, Bolton Medical Inc.

38. Global Endovascular Stent Grafts Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Endovascular Stent Grafts Market

40. Endovascular Stent Grafts Market High Potential Countries, Segments and Strategies

  • 40.1 Endovascular Stent Grafts Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Endovascular Stent Grafts Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Endovascular Stent Grafts Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer